The forecasted mortality rates for trachea, bronchus, and lung malignant neoplasms among women in Canada show a declining trend from 40.9 per 100,000 in 2024 to 39.1 in 2028. Compared to 2023, the rate was slightly higher, but specific earlier data isn't provided to establish percentage variation. The year-on-year decline from 2024 to 2028 averages to a CAGR decrease of around 1.1%. This downward trend likely reflects ongoing public health efforts and medical advancements aimed at reducing smoking rates and improving cancer treatment and screening.
Future trends to monitor include possible impacts of emerging technologies in early cancer detection, the effects of policy changes in smoking regulations, and the introduction of advanced therapies targeting lung cancer, which could further drive down mortality rates.
